What if the secret to faster and more effective cancer treatments isn't found in conventional laboratories but within the algorithms of artificial intelligence instead? Drug development has long been a drawn-out process, often taking over a decade to bring a new medication from concept to market.
The pediatric imaging market, currently valued at $8.7 billion, has attracted significant attention due to its anticipated growth trajectory towards $18.1 billion by 2034. This remarkable expansion is driven in part by a projected compound annual growth rate of 7.7% from 2025 to 2034, indicating a
Recent advancements in artificial intelligence have significantly transformed various domains of healthcare, and dementia diagnosis is no exception. Dementia has emerged as a global health concern, impacting over 55 million individuals worldwide, with a significant proportion suffering from
In a major breakthrough in the field of drug development, revolutionary nanotechnology known as Facilitated Self-Assembling Technology (FAST) has been unveiled, promising to drastically transform drug solubility. Spearheaded by Stephen Hsu, PhD, a professor at the Dental College of Georgia, FAST
In the rapidly evolving landscape of healthcare and artificial intelligence, Ivan Kairatov stands out as a leading voice, particularly when it comes to understanding the complex intersection of bioethics, law, and technology in the biopharma industry. His extensive experience in research and
The unforeseen impact of the COVID-19 pandemic initiated a global rush not only to discover vaccines but also to explore effective antiviral drugs capable of counteracting multiple coronaviruses. This effort has evolved beyond traditional scientific methods, incorporating surprising and innovative
